2017
DOI: 10.5935/0101-2800.20170019
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of economic impact among modalities of renal replacement therapy

Abstract: After the first two years of renal replacement therapy, transplantation demonstrates lower costs to the system when compared to other modalities evaluated. Based on that, this therapy justifies improvements in government policies in this sector.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
22
0
9

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(40 citation statements)
references
References 0 publications
0
22
0
9
Order By: Relevance
“…And compared with hemodialysis, the low cost of APD treatment can reduce the economic burden of patients to a large extent. 38 This study was a single-center, retrospective cohort study with a relatively small sample size. Therefore, the clinical application of APD in the perioperative period of peritoneal dialysis still needs to be further confirmed by multicenter clinical research.…”
Section: Discussionmentioning
confidence: 99%
“…And compared with hemodialysis, the low cost of APD treatment can reduce the economic burden of patients to a large extent. 38 This study was a single-center, retrospective cohort study with a relatively small sample size. Therefore, the clinical application of APD in the perioperative period of peritoneal dialysis still needs to be further confirmed by multicenter clinical research.…”
Section: Discussionmentioning
confidence: 99%
“…Além desses, 12 milhões apresentam algum grau de disfunção renal já estabelecida, cujo tratamento conservador consiste em retardar a perda da função dos rins, reduzir os sintomas e prevenir complicações ligadas à doença. Ainda mais preocupante é a constatação de que, aproximadamente, 122.000 renais crônicos em estágio avançado dependem do tratamento dialítico ou transplante para sobreviverem, a um custo de R$ 1,4 bilhão para os cofres públicos e privados [1][2][3][4] .…”
Section: Introductionunclassified
“…Segundo a análise do "Global Burden of Disease Study 2017" 3 , dentre 282 causas de mortes em 195 países entre os anos de 1980 e 2017, a doença renal configurou como a 16ª causa de óbitos nesse período com crescente prevalência. Apesar dos avanços tecnológicos, a mortalidade dos pacientes renais é em torno de 15% ao ano, sendo maior no início da terapia por conta do diagnóstico tardio 4 .…”
Section: Introducãounclassified